Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Shifting paradigms in the systemic management of hepatocellular carcinoma.

  • Authors : Pinato DJ; Department of Surgery and Cancer, Imperial College London, Faculty of Medicine, Hammersmith Hospital, London W12 0NN, UK. Electronic address: .

Subjects: Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*therapy ; Immunotherapy/Immunotherapy/Immunotherapy/*methods ; Liver Neoplasms/Liver Neoplasms/Liver Neoplasms/*pathology

  • Source: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2020 Oct; Vol. 5 (10), pp. 883-885.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective.

  • Authors : Barry A; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada; Radiation Medicine Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada. Electronic address: .

Subjects: Pandemics*; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*therapy ; Coronavirus Infections/Coronavirus Infections/Coronavirus Infections/*epidemiology COVID-19severe acute respiratory syndrome coronavirus 2

  • Source: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2020 Aug; Vol. 5 (8), pp. 765-775. Date of Electronic Publication: 2020 Jun 06.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Adjuvant 131 I-metuximab in hepatocellular carcinoma: a new option for an old drug?

  • Authors : Vogel A; Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover 30625, Germany. Electronic address: .; Saborowski A

Subjects: Carcinoma, Hepatocellular* ; Liver Neoplasms*; Antibodies, Monoclonal

  • Source: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2020 Jun; Vol. 5 (6), pp. 517-519. Date of Electronic Publication: 2020 Mar 09.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Adjuvant 131 I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial.

  • Authors : Li J; Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.; Xing J

Subjects: Hepatectomy*; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*radiotherapy

  • Source: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2020 Jun; Vol. 5 (6), pp. 548-560. Date of Electronic Publication: 2020 Mar 09.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

A panel of five plasma proteins for the early diagnosis of hepatitis B virus-related hepatocellular carcinoma in individuals at risk.

  • Authors : Cheng K; Changhai Hospital, Second Military Medical University, Shanghai, China.; Shi J

Subjects: Biomarkers, Tumor* ; Blood Proteins*; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*diagnosis

  • Source: EBioMedicine [EBioMedicine] 2020 Feb; Vol. 52, pp. 102638. Date of Electronic Publication: 2020 Jan 31.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms.

  • Authors : Chen J; Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, 100 Blossom St, Cox-734, Boston, MA 02114, USA; Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou 310016, China. Electronic address: .

Subjects: Carcinoma, Hepatocellular* ; Liver Neoplasms*; Humans

  • Source: EBioMedicine [EBioMedicine] 2020 Feb; Vol. 52, pp. 102644. Date of Electronic Publication: 2020 Jan 31.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.

  • Authors : Xiao Y; State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal University, Changsha, 410081, China; Key Laboratory of Protein Chemistry and Development Biology of State Education Ministry of China, College of Life Science, Hunan Normal University, Changsha, 410081, China

Subjects: Down-Regulation*; Adaptor Proteins, Signal Transducing/Adaptor Proteins, Signal Transducing/Adaptor Proteins, Signal Transducing/*metabolism ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*metabolism

  • Source: EBioMedicine [EBioMedicine] 2020 Jan; Vol. 51, pp. 102603. Date of Electronic Publication: 2020 Jan 03.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma.

  • Authors : Xia S; Key Laboratory of Laparoscopic Technology of Zhejiang Province, Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.; Pan Y

Subjects: Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/drug effects ; Tumor Microenvironment*/Tumor Microenvironment*/Tumor Microenvironment*/drug effects ; Tumor Microenvironment*/Tumor Microenvironment*/Tumor Microenvironment*/genetics

  • Source: EBioMedicine [EBioMedicine] 2020 Jan; Vol. 51, pp. 102610. Date of Electronic Publication: 2020 Jan 06.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

PRAS40 hyperexpression promotes hepatocarcinogenesis.

  • Authors : Qi Z; Department of Pathophysiology, College of Basic Medical Sciences, Dalian Medical University, 9 South Lvshun Road, Dalian, Liaoning 116044, PR China.; Zhang T

Subjects: Adaptor Proteins, Signal Transducing/Adaptor Proteins, Signal Transducing/Adaptor Proteins, Signal Transducing/*metabolism ; Carcinogenesis/Carcinogenesis/Carcinogenesis/*metabolism ; Carcinogenesis/Carcinogenesis/Carcinogenesis/*pathology

  • Source: EBioMedicine [EBioMedicine] 2020 Jan; Vol. 51, pp. 102604. Date of Electronic Publication: 2020 Jan 03.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.

  • Authors : Ji GW; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, PR China; Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, Nanjing, PR China

Subjects: Machine Learning* ; Radiographic Image Enhancement* ; Tomography, X-Ray Computed*/Tomography, X-Ray Computed*/Tomography, X-Ray Computed*/methods

  • Source: EBioMedicine [EBioMedicine] 2019 Dec; Vol. 50, pp. 156-165. Date of Electronic Publication: 2019 Nov 15.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited

Record details

×
  • 1-10 of  91 results for ""Liver Neoplasms""